Trial Profile

Anticoagulant treatments evaluation during percutaneous coronary angioplasty in stable patients.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin; Bivalirudin; Clopidogrel; Enoxaparin sodium; Heparin
Indications Thrombosis
Focus Therapeutic Use
Acronyms TACA

Most Recent Events

17 May 2019 Biomarkers information updated
01 Jul 2011 Planned end date changed from 1 Sep 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.
08 Jun 2008 Status changed from initiated to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com